Colin H. Mackie

enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.

Exogenesis Corp. processes implantable medical devices and other medical products. It is engaged in development activities with a number of partners and is interested in exploring new applications for its technology in biomedical and non-medical applications with partners interested in improving the properties and performance of materials. The company was founded by Richard C. Svrluga in 2005 and is headquartered in Billeric, MA.

Bio Response, Inc. provides marketing and distribution services. The private company is based in Brooklyn, NY and has subsidiaries in the United States.

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.